Protalix BioTherapeutics, Inc. (DE)
IPOProtalix.com
Public · Carmiel, Israel · Founded 1993 · $52.6M raised
- Headquarters
- Carmiel
- Employees
- 51–200
- Founded
- 1993
- Business Model
- B2B
- Website
- protalix.com
- Total Funding
- $52.6M
- Last Round
- $43.7M Growth EquityMar 2020
- Rounds
- 3
- Type
- Public
About
Biopharmaceutical company developing recombinant therapeutic proteins using proprietary plant cell-based expression system for rare diseases.
Summary
Protalix BioTherapeutics, Inc. (DE) is a Biotech company based in Carmiel, Israel, founded in 1993. It has raised $52.6M in total across 3 rounds, most recently a $43.7M Growth Equity round in Mar 2020. Investors include Pontifax.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2020
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...